Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001012975-18-000467)

Filing Details

Accession Number:: 0001012975-18-000467
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-29 18:17:36
Reporting Period:: 2018-05-25

Accepted Time:: 2018-05-29 18:17:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326190	Altimmune Inc.	ALT	Pharmaceutical Preparations (2834)	202726770

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1705564	William Enright	C/O Altimmune, Inc. 910 Clopper Road, Suite 201S Gaithersburg MD 20878	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001	Acquisiton	2018-05-25	1,300	$0.51	365,839	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The transaction was executed in multiple trades at prices ranging from $0.505151 to $0.5088. The price above reflects the weighted average purchase price. Detailed information regarding the number of shares purchased at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.